Such contradictory effects of TERTp mutation on patient outcome between groups have been reported previously (11). Aibaidula et al. found comparable results to those of Pekmezci et al., and concluded that adult IDH-WT lower-grade gliomas should be further classified by TERTp mutation status (35). This evidence concerns the gene IDH2 and glioma.